A CONTROLLED TRIAL OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER TOTAL-BODY IRRADIATION, HIGH-DOSE CHEMOTHERAPY, AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC-LEUKEMIA OR MALIGNANT-LYMPHOMA

被引:0
|
作者
LINK, H
BOOGAERTS, MA
CARELLA, AM
FERRANT, A
GADNER, H
GORIN, NC
HARABACZ, I
HAROUSSEAU, JL
HERVE, P
HOLLDACK, J
KOLB, HJ
KRIEGER, O
LABAR, B
LINKESCH, W
MANDELLI, F
MARANINCHI, D
NAPARSTEK, E
NICOLAY, U
NIEDERWIESER, D
REIFFERS, J
RIZZOLI, V
SIEGERT, W
VERNANT, JP
DEWITTE, T
机构
[1] CATHOLIC UNIV LEUVEN, MED CTR, DEPT HEMATOL, B-3000 LOUVAIN, BELGIUM
[2] OSPED SAN MARTINO GENOVA, DEPT HEMATOL, GENOA, ITALY
[3] CLIN UNIV ST LUC, DEPT HEMATOL, B-1200 BRUSSELS, BELGIUM
[4] ST ANNA CHILDRENS HOSP, DEPT PEDIAT HEMATOL & ONCOL, VIENNA, AUSTRIA
[5] HOP ST ANTOINE, DEPT HEMATOL, F-75571 PARIS 12, FRANCE
[6] HOP HOTEL DIEU, DEPT HEMATOL, NANTES, FRANCE
[7] UNIV BESANCON, MED CTR, DEPT HEMATOL, F-25030 BESANCON, FRANCE
[8] UNIV MUNICH, MED CTR, DEPT HEMATOL, W-8000 MUNICH 2, GERMANY
[9] HANUSCH HOSP, DEPT LEUKEMIA RES & HEMATOL, VIENNA, AUSTRIA
[10] UNIV ZAGREB, MED CTR, DEPT HEMATOL, YU-41001 ZAGREB, CROATIA
[11] UNIV VIENNA, MED CTR, DEPT HEMATOL, A-1010 VIENNA, AUSTRIA
[12] UNIV ROME LA SAPIENZA, POLICLIN UMBERTO 1, DEPT HEMATOL, I-00185 ROME, ITALY
[13] INST J PAOLI I CALMETTES, DEPT HEMATOL, F-13009 MARSEILLE, FRANCE
[14] HADASSAH UNIV HOSP, DEPT BONE MARROW TRANSPLANTAT, JERUSALEM, ISRAEL
[15] UNIV INNSBRUCK, MED CTR, DEPT IMMUNOBIOL, A-6020 INNSBRUCK, AUSTRIA
[16] HOP HAUT LEVEQUE, DEPT HEMATOL, PESSAC, ITALY
[17] UNIV PARMA, MED CTR, DEPT HEMATOL, I-43100 PARMA, ITALY
[18] FREE UNIV BERLIN, KLINIKUM CHARLOTTENBURG, MED CTR, DEPT HEMATOL & ONCOL, W-1000 BERLIN 19, GERMANY
[19] HOP HENRI MONDOR, DEPT HEMATOL, F-94010 CRETEIL, FRANCE
[20] CATHOLIC UNIV NIJMEGEN, MED CTR, DEPT HEMATOL, NIJMEGEN, NETHERLANDS
[21] BEHRINGWERKE AG, W-3550 MARBURG, GERMANY
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2188 / 2195
页数:8
相关论文
共 50 条
  • [1] EFFECT OF RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR ON HEMATOPOIETIC RECONSTITUTION AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    BRANDT, SJ
    PETERS, WP
    ATWATER, SK
    KURTZBERG, J
    BOROWITZ, MJ
    JONES, RB
    SHPALL, EJ
    BAST, RC
    GILBERT, CJ
    OETTE, DH
    NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (14): : 869 - 876
  • [2] DISPOSITION OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS RECEIVING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT
    PETROS, WP
    RABINOWITZ, J
    STUART, AR
    GILBERT, CJ
    KANAKURA, Y
    GRIFFIN, JD
    PETERS, WP
    BLOOD, 1992, 80 (05) : 1135 - 1140
  • [3] RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR LYMPHOID CANCER
    NEMUNAITIS, J
    RABINOWE, SN
    SINGER, JW
    BIERMAN, PJ
    VOSE, JM
    FREEDMAN, AS
    ONETTO, N
    GILLIS, S
    OETTE, D
    GOLD, M
    BUCKNER, CD
    HANSEN, JA
    RITZ, J
    APPELBAUM, FR
    ARMITAGE, JO
    NADLER, LM
    NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (25): : 1773 - 1778
  • [4] LACK OF EFFECT ON PLATELET INCREMENTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MALIGNANT-LYMPHOMA
    CHAMBERS, LA
    GARCIA, LW
    TRANSFUSION, 1994, 34 (03) : 221 - 225
  • [5] Recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma
    Fay, JW
    Bernstein, SH
    SEMINARS IN ONCOLOGY, 1996, 23 (02) : 22 - 27
  • [6] THE USE OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION
    NEMUNAITIS, J
    SINGER, JW
    CANCER INVESTIGATION, 1993, 11 (02) : 224 - 228
  • [7] RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION WITH UNPURGED AND PURGED MARROW IN NON-HODGKINS-LYMPHOMA - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    GORIN, NC
    COIFFIER, B
    HAYAT, M
    FOUILLARD, L
    KUENTZ, M
    FLESCH, M
    COLOMBAT, P
    BOIVIN, P
    SLAVIN, S
    PHILIP, T
    BLOOD, 1992, 80 (05) : 1149 - 1157
  • [8] GRANULOCYTE COLONY-STIMULATING FACTOR AND NEUTROPHIL RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    SHERIDAN, WP
    WOLF, M
    LUSK, J
    LAYTON, JE
    SOUZA, L
    MORSTYN, G
    DODDS, A
    MAHER, D
    GREEN, MD
    FOX, RM
    LANCET, 1989, 2 (8668): : 891 - 895
  • [9] RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR AFTER BONE-MARROW TRANSPLANTATION
    LINK, H
    KIRCHNER, H
    FREUND, M
    STOLL, M
    SEIDEL, J
    SCHMID, H
    SCHMIDT, RE
    BUCSKY, P
    SCHULZ, G
    RIEHM, H
    POLIWODA, H
    WELTE, K
    BONE MARROW TRANSPLANTATION, 1988, 3 : 92 - 92
  • [10] RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MALIGNANT-LYMPHOMA - A BRITISH NATIONAL LYMPHOMA INVESTIGATION DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    KHWAJA, A
    LINCH, DC
    GOLDSTONE, AH
    CHOPRA, R
    MARCUS, RE
    WIMPERIS, JZ
    RUSSELL, NH
    HAYNES, AP
    MILLIGAN, DW
    LEYLAND, MJ
    WINFIELD, DA
    HANCOCK, BW
    NEWLAND, A
    DURRANT, ST
    DEVEREUX, S
    ROITT, S
    COLLINS, M
    HUDSON, GV
    BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (02) : 317 - 323